Walleye Capital’s Itron ITRI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$649K Buy
7,500
+4,300
+134% +$367K ﹤0.01% 2487
2026
Q1
$287K Buy
+3,200
New +$307K ﹤0.01% 3093
2024
Q3
Sell
-200
Closed -$19.8K 5572
2024
Q2
$19.8K Buy
+200
New +$20.1K ﹤0.01% 5121
2024
Q1
Sell
-1,300
Closed -$98.2K 5631
2023
Q4
$98.2K Buy
+1,300
New +$84.5K ﹤0.01% 4050
2023
Q3
Sell
-1,500
Closed -$108K 5095
2023
Q2
$108K Buy
+1,500
New +$94.9K ﹤0.01% 3397
2020
Q1
Sell
-1,000
Closed -$84K 1297
2019
Q4
$84K Buy
+1,000
New +$78.7K 0.01% 1401

Other funds holding ITRI

Walleye Capital's ITRI Position: Q2 2026 in Review

Walleye Capital reduced its Itron (ITRI) stake by 4.4% in Q2 2026, selling an estimated $52.9K and leaving 13,431 shares worth $1.16M. The position accounts for ﹤0.01% of the portfolio, ranked #1987.

Walleye Capital first reported a position in ITRI in Q4 2019 and has held it in 13 quarters since. The position peaked at $3.17M in Q2 2025. 413 funds tracked by Wall St. Rank hold ITRI as of Q2 2026.

  • Walleye Capital held 13,431 shares of Itron worth $1.16M as of Q2 2026.
  • Walleye Capital sold 620 Itron shares in Q2 2026, an estimated $52.9K.
  • Itron made up ﹤0.01% of Walleye Capital's portfolio in Q2 2026, its #1987 holding.
  • Walleye Capital first reported a position in Itron in Q4 2019 and has held it in 13 quarters since.
  • Walleye Capital's Itron position peaked at $3.17M in Q2 2025.
  • 413 funds tracked by Wall St. Rank held Itron as of Q2 2026.

Based on Walleye Capital's 13F filing for Q2 2026, filed 3 Aug 2026.